Valeritas Holdings Inc (NASDAQ:VLRX)’s share price traded up 10.7% during trading on Wednesday . The stock traded as high as $1.03 and last traded at $1.14. 7,214 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 224,836 shares. The stock had previously closed at $1.03.
Several equities research analysts have weighed in on the company. Oppenheimer assumed coverage on Valeritas in a report on Thursday, July 5th. They issued an “outperform” rating and a $3.50 target price for the company. Citigroup assumed coverage on Valeritas in a report on Thursday, July 5th. They issued an “outperform” rating and a $3.50 target price for the company. ValuEngine upgraded Valeritas from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd. Finally, assumed coverage on Valeritas in a report on Thursday, July 5th. They issued an “outperform” rating and a $3.50 target price for the company. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $3.67.
The firm has a market capitalization of $22.74 million, a P/E ratio of -0.12 and a beta of 4.14. The company has a debt-to-equity ratio of 13.66, a current ratio of 4.03 and a quick ratio of 3.42.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Bainco International Investors acquired a new stake in Valeritas in the 2nd quarter valued at $228,000. Essex Investment Management Co. LLC acquired a new stake in shares of Valeritas during the second quarter valued at about $448,000. Finally, C WorldWide Group Holding A S grew its stake in shares of Valeritas by 28.0% during the second quarter. C WorldWide Group Holding A S now owns 316,194 shares of the company’s stock valued at $424,000 after acquiring an additional 69,216 shares in the last quarter. Hedge funds and other institutional investors own 7.38% of the company’s stock.
About Valeritas (NASDAQ:VLRX)
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
Featured Story: Momentum Indicator: Relative Strength Index
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.